Upcoming Events - Earnings (2/9/21 *Est.) Today 6M 1Y 5Y. Get the latest news and analysis in the stock market today, including national and world stock market news, business news, financial news and more At Abbott, we help people live fully with our life-changing technology. Stocks USA. View the latest AbbVie Inc. (ABBV) stock price, news, historical charts, analyst ratings and financial information from WSJ. Earnings Estimate. By 2025, AbbVie will have at least one wholly new drug on the market as well as a handful of newly approved indications for its older drugs. Today's Research Daily features new research reports on 16 major stocks, including Facebook, Inc. (FB), Netflix, Inc. (NFLX) and AbbVie Inc. (ABBV). 3 Large-Cap Dividend Stocks to Buy and Hold Before 2021 . ABBV --0.00%--AbbVie Reports Will Present New Data From 18 Abstracts At International Congress of Parkinson's Disease and Movement Disorders® Sept. 12-16. HOME MARKET TRADE PRICING DOWNLOAD HELP. ABBV -- USA Stock : USD 97.16 0.03 0.0309% : We are showing AbbVie news for the 28th of July in timeline form. This is yet another view into AbbVie filtered headlines to … AbbVie Stock News Timeline Today. Today's Low. AbbVie's funding will provide mentorship in three new cities and expand existing programs in 11 cities to improve post-secondary success. The cash dividend is payable November 16, 2020 to stockholders of record at the close of business on October 15, 2020.. So, if you are looking for a decent pick in a strong industry, consider AbbVie. LOG IN. ABBV stock fell 3.7% to 92.25 on the stock market today.Shares of ABBV stock touched a nearly three-month low. It now expects adjusted EPS of $10.47 to $10.49 as compared to the previous $10.35 to $10.45. You can see the complete list of today’s Zacks #1 Rank stocks here. We keep your heart healthy, nourish your body at every stage of life, help you feel and move better, and bring you information, medicines and breakthroughs to manage your health. Partner Perspectives . Calendar. Since the company's inception in 2013, AbbVie has increased its dividend by 195 percent. ABBV Stock Drops On Subpoena News. Consensus. Stocks USA. NORTH CHICAGO, Ill., Sept. 11, 2020 /PRNewswire/ -- The board of directors of AbbVie Inc. (NYSE: ABBV) today declared a quarterly cash dividend of $1.18 per share. Stock AbbVie Inc. Summary; Performance; Fundamentals; Technicals; Recommendation; Quick Advice. ... As part of today's announcement, AbbVie is expanding its employee matching program to $3-to-$1 for donations to civil rights nonprofits fostering racial equity. It is done using both, our quantitative analysis of the company fundamentals as well as its intrinsic market price estimation to project the real value. Richard A. Gonzalez, chairman and chief executive officer, will present at 10 a.m. Central time. News Timeline. 4. Today, our passionate AbbVie team has approximately 47,000 employees working together to help patients around the world. 6 days ago. 62.55 ... Abbvie's Rinvoq Meets Primary And All Ranked Secondary Endpoints In Ulcerative Colitis study . AbbVie Inc. (ABBV) Quote Overview » News » AbbVie Inc. (ABBV) Zacks News . Based in North Chicago, AbbVie (ABBV) is in the Medical sector, and so far this year, shares have seen a price change of 4.02%. AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference PR Newswire (Press Release) 13:17 24-Nov-20 News briefing: AbbVie partner Teneobio expands tech license with CAR-T player Poseida; Argenx buys PRV from Bayer for… This is yet another view into AbbVie filtered headlines to … Earnings Estimate. AbbVie shares were trading up 5.03% at $84.73 at last check Friday. Get Abbvie Inc (ABBV:NYSE) real-time stock quotes, news and financial information from CNBC. NORTH CHICAGO, Ill., Dec. 5, 2020 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced new, updated results from the Phase 3 MURANO and CLL14 clinical trials evaluating VENCLEXTA ® /VENCLYXTO ® (venetoclax) fixed duration treatment combinations at the virtual 62 nd American Society of Hematology (ASH) Annual Meeting & Exposition (abstracts 125, 127, and 1310, respectively). AbbVie (ABBV) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). Consensus. Exposure. Today, AbbVie medicines help approximately 52 million people living in more than 175 countries, and AbbVie is making significant advancements with a robust pipeline of potential new … Allergan, An AbbVie Company, Announces Positive Phase 3 Topline Results For Investigational AGN-190584 For The Treatment Of Presbyopia By PR Newswire Oct 28, 2020 8:00 AM EDT These … 109.14: 52 Week Low. AbbVie (NYSE:ABBV) declares $1.30/share quarterly dividend, 10.2% increase from prior dividend of $1.18.Forward yield 6.45%Payable Feb. … 105.59: 52 Week High . AbbVie discovers, develops, and commercializes advanced therapies that have an impact on people's lives. News. SIGN UP. - M&A (11/30/-1 *Est) - M&A (12/31/16 *Est) Latest Headlines. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. AbbVie Stock News Timeline Today. ABBVie today announced new, updated results from the Phase 3 MURANO and CLL14 clinical trials evaluating VENCLEXTA ® VENCLYXTO ® fixed duration treatment combinations at … Stock AbbVie Inc. Summary; Performance; Fundamentals; Technicals; Recommendation; Quick Advice. AbbVie (NYSE:ABBV) today announced it will present results from several studies, … Webull offers ABBV stock news, real time AbbVie news help you invest smart. This is technology at its most personal, the kind that helps you live healthier so you can do the things you love. AbbVie to Present at the Evercore ISI Conference and Piper Sandler Healthcare Conference PR Newswire (Press Release) 08:17 24-Nov-20 News briefing: AbbVie partner Teneobio expands tech license with CAR-T player Poseida; Argenx buys PRV from Bayer for… Zacks News . AbbVie joined the antibody hunt back in June, with its sights set on Harbour’s 47D11. AbbVie Valuation Module provides a unique way to ballpark how much the company is worth today. The recently announced acquisition of Allergan will add several new drugs in aesthetics and women's health. The AbbVie earnings news also has it updated its guidance for the full year of 2020. Calendar. News Timeline. Exposure. A high-level overview of AbbVie Inc. (ABBV) stock. ABBV -- USA Stock : USD 95.77 1.60 1.70% : We are showing AbbVie news for the 1st of September in timeline form.